BiomX ( (PHGE) ) has provided an announcement.

On April 13, 2026, BiomX exercised an exclusive option and closed a Stock Purchase & Assignment Agreement with Mandragola Ltd. to acquire 100% of Mandragola’s holdings in DR. Frucht Systems Ltd., giving BiomX control of 60% of DFSL’s equity and making it a majority-owned operating subsidiary. The consideration package combines $750,000 in cash, a $3 million unsecured convertible note, common shares and warrants subject to shareholder approval, and a revenue-based bonus tied to DFSL achieving at least $25 million in annual sales from 2027.

DFSL’s LADAR-based detection systems, which use laser sensing and proprietary AI algorithms to reduce false alarms and track aerial and ground threats in real time, are intended to complement BiomX’s recently acquired Zorronet AI command-and-control platform and strengthen its position in AI-enabled security and defense solutions. The deal, conducted as a private offering under U.S. securities rules and contingent on Israeli regulatory and NYSE American shareholder approvals for certain issuances, signals BiomX’s accelerated push into defense, critical infrastructure, and first-response markets, supported by a planned Mandragola credit line to fund DFSL’s growth and debt obligations.

The most recent analyst rating on (PHGE) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on BiomX stock, see the PHGE Stock Forecast page.